Surprisingly, we found that inhibition of IL-21 and IL-23 also reduced RANKL expression significantly on RA CD4+ T cells derived from PBMCs and SF, both independently and when inhibited together (Figures 6A–H). Here, CD4 is linked to rheumatoid arthritis.